|
Category :
Company News
Headline :
Envair Electrodyne - Board Meeting Outcome for Board Meeting Outcome For Regulation 30 Read With Part A Of Schedule III And R
Date:
13/02/2024 14:06
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, a meeting of the Board of Directors held on 13th February 2024, at 01:15 pm and concluded at 01:50 PM inter alia, approved the following: \r\n1. Standalone Unaudited Financial Results for the Quarter ended 31st December 2023 along with Limited Review Report. \r\n2. To Approve Appointment of M/s Sanger & Associates as Secretarial Auditor for financial year 2023-24.\r\n
|